Latest Breaking News On - Xavier salvatella - Page 1 : comparemela.com

<ul> <li>Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge.</li> <li>An international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia) and other institutions has discovered a potential way to target the androgen receptor, the most prominent oncogenic transcription factor in prostate cancer, based on its propensity to form droplets also known as condensates.</li> <li>The results described in this publication set the basis for the foundation of Nuage Therapeutics, a spinoff of IRB Barcelona and ICREA.</li> <li>The findings are published in <em>Nature Structural &amp; Molecular Biology</em>.</li> </ul>

Comunidad autonoma de catalunaUnited kingdomJudit anidoDenes hniszMarianne sadarShaon basuMateusz biesagaPaula martMarianned sadarXavier salvatellaUniversity of barcelonaMax planck institute for molecular geneticsBc cancer university of british columbiaInstitute for researchMax planck instituteMolecular genetics